PU-H71 HCl ( —— )

产品货号. M36291 CAS No. 2095432-24-7

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

PU-H71 HCl
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT. PU-H71 HCL shows antitumor activity in many preclinical models of malignancy. PU-H71 HCL has an inhibitory effect on the protein expression levels of Rad51 and Ku70, which may be associated with the double chain break repair in the homologous recombination pathway and non-homologous end-joining pathway.
产品描述

PU-H71 HCl (Zelavespib HCl) is a novel Hsp90 inhibitor, a novel purine-based analog, and a radiosensitizer that may be a promising agent for CIRT. PU-H71 HCL shows antitumor activity in many preclinical models of malignancy. PU-H71 HCL has an inhibitory effect on the protein expression levels of Rad51 and Ku70, which may be associated with the double chain break repair in the homologous recombination pathway and non-homologous end-joining pathway.
体外实验

——
体内实验

——
同义词

——
通路

Cytoskeleton/Cell Adhesion Molecules
靶点

HSP
受体

HSP | DNA/RNA Synthesis
研究领域

——
适应症

——

计算器

产品手册

关联产品

Momordin Ic

Momordin Ic 可能具有潜在的抗癌活性，通过氧化应激调节的线粒体功能障碍（涉及 MAPK 和 PI3K 介导的 iNOS 和 HO-1 途径）诱导细胞凋亡。
AMP-PCP

AMP-PCP 是 ATP 类似物，可以结合 Hsp90 N 末端结构域，Kd 值为 3.8 μM。 AMP-PCP 结合有利于 Hsp90 活性同二聚体的形成。
JG-98

JG-98 是一种变构 Hsp70 抑制剂，对乳腺癌细胞系 MDA-MB-231 和 MCF-7 的活性和稳定性比 MKT-077 高 3 倍以上（EC50 分别为 0.4 uM 和 0.7 uM）。